Literature DB >> 25057955

The natural history of primary biliary cirrhosis.

Mohamad H Imam1, Keith D Lindor2.   

Abstract

Our understanding of the natural history of primary biliary cirrhosis (PBC) has been evolving especially following the introduction of ursodeoxycholic acid (UDCA). A clearer understanding of disease pathophysiology and earlier diagnosis with increased prevalence of the disease worldwide has led to increased interest and improved outcomes in patients with PBC. In this article, the authors touch briefly on features of the disease and describe the natural history of PBC prior to and after the introduction of UDCA. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25057955     DOI: 10.1055/s-0034-1383731

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  9 in total

Review 1.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

2.  Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.

Authors:  Nidah Shabbir Khakoo; Shahnaz Sultan; John M Reynolds; Cynthia Levy
Journal:  Dig Dis Sci       Date:  2022-09-30       Impact factor: 3.487

Review 3.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08

4.  Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.

Authors:  Binu V John; Nidah S Khakoo; Kaley B Schwartz; Gabriella Aitchenson; Cynthia Levy; Bassam Dahman; Yangyang Deng; David S Goldberg; Paul Martin; David E Kaplan; Tamar H Taddei
Journal:  Am J Gastroenterol       Date:  2021-09-01       Impact factor: 12.045

5.  A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary Cirrhosis.

Authors:  P Zuo; R L Dobbins; R L O'Connor-Semmes; M A Young
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-08-18

6.  Increased red cell width distribution to lymphocyte ratio is a predictor of histologic severity in primary biliary cholangitis.

Authors:  Jing Meng; Hongqin Xu; Xu Liu; Ruihong Wu; Junqi Niu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

7.  Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States.

Authors:  Omer Shahab; Mehmet Sayiner; James Paik; Sean Felix; Pegah Golabi; Zobair M Younossi
Journal:  Hepatol Commun       Date:  2019-01-28

8.  Natural history of grade 1 ascites in patients with liver cirrhosis.

Authors:  Theodoros Theodorakopoulos; Maria Kalafateli; Georgios N Kalambokis; Dimitrios N Samonakis; Ioanna Aggeletopoulou; Chrysostomos Tsolias; Aikaterini Mantaka; Paraskevi Tselekouni; Georgia Vourli; Stelios F Assimakopoulos; Charalampos Gogos; Konstantinos Thomopoulos; Haralampos Milionis; Christos Triantos
Journal:  Ann Gastroenterol       Date:  2020-11-20

9.  Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up.

Authors:  Peter Deibert; Adhara Lazaro; Zoran Stankovic; Denise Schaffner; Martin Rössle; Wolfgang Kreisel
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.